CXCL12 and ovarian carcinoma: In ovarian cancer TME, CXCL12 is secreted by several cells [39,40] and drives Tregs recruitment, inhibits leukocytes and facilitates M2 macrophage polarization, driving the TME toward an immunosuppressive status [41].